Lupin has acquired acclaim for its Sevelamer Hydrochloride Tablets, 400 mg and 800 mg from the US Food and Drug Administration to market a ordinary equivalent of Renagel Tablets, 400 mg and 800 mg, of Genzyme Corporation. The product can be manufactured at Lupin’s facility in Nagpur, India.
Sevelamer Hydrochloride Tablets are indicated for the manipulate of serum phosphorus in patients with persistent kidney disorder (CKD) on dialysis.
Bazaarinformation team has many years of experience, covering the physical and future commodities markets with prominent commodity & equity trading advising which shines further with extensive network to get research from ground levels to generate proper reporting and movements. We are able to get evens out of odds in volatile markets and stockings. ...
